2018 Editorial Calendar


Q1

Jan

Insiders πŸ”

The class of 2017’s winners and losers: A year of ‘nonstop scientific achievements’ raises troubling issues

Jan

Special

The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds

Jan

Insiders πŸ”

Where the money is: the top 100 VCs investing in biotech during 2017

1/9

Event

Video — Panel at #JPM18: Where is the cancer R&D revolution headed?

1/23

Special

Top 10 pipeline blowups, setbacks and snafus in H2 2017

Feb

Special

The Endpoints 100 Survey

Feb

Insiders πŸ”

The 25 most influential people in biopharma

Mar

Deep Dive

Alzheimer’s R&D Revisited

Mar

Insiders πŸ”

Top 20 cancer drugs by revenue

 


Q2

4/2

Insiders πŸ”

Top 15 R&D budgets

4/9

Special

Top Q1 pipeline blowups

4/16

Special

Q1 IPO report

4/17

Deep Dive

Depression: replacing a generation of ineffective therapies

5/7

Insiders πŸ”

Top 15 biopharma companies by revenue

5/14

Deep Dive

The immunotherapy strategy report

5/29

Insiders πŸ”

Top 10 immunotherapy drugs in the pipeline

6/1

Special

ASCO special weekend event coverage

June

Special

BIO convention coverage

6/6

Event

The ROI β€” executive breakfast panel

6/18

Deep Dive

The ROI on drug development

6/25

Insiders πŸ”

Top 20 pipeline drugs

 

Q3

7/2

Special

Top Q2 pipeline blowups

7/3

Insiders πŸ”

H1 venture capital report

7/16

Insiders πŸ”

Q2 IPO report

7/17

Deep Dive

Protecting patents, or excluding competition?

7/22

Event

The new wave of Alzheimer’s researchers (Chicago)

8/6

Special

The Endpoints 100 Survey

9/3

Special

The 2018 Endpoints 11

9/17

Deep Dive

Top 20 cancer drugs in late-stage pipeline


Q4

10/3

Insiders πŸ”

Q3 IPO report

10/8

Special

Top Q3 pipeline blowups

10/15

Deep Dive

Post-Brexit UK: A look at the Golden Triangle

10/19

Event

ESMO news coverage

10/25

Event

Biotech panel in London

11/19

Deep Dive

The late-stage players in the NASH pipeline

12/1

Event

ASH news coverage

12/1

Deep Dive

Diabetes and obesity R&D


For sponsorship opportunities please contact Arsalan Arif β€” aa@endpointsnews.com